Showing results (391-400 of 440) with videos related to
Sort By:
Pageof 44
Scientific Reports|December 10, 2015
Loss of synaptic Zn2+ transporter function increases risk of febrile seizuresMichael S Hildebrand, A Marie Phillips, Saul A Mullen, et al.Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.Science (New York, N.Y.)|October 20, 1995
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 yearsR M Blaese, K W Culver, A D Miller, et al.Journal of Pediatric Surgery|January 22, 2013
Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committeeKenneth W Gow, Douglas C Barnhart, Thomas E Hamilton, et al.Pediatric Blood & Cancer|July 21, 2020
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumorKevin X Liu, Natalie B Collins, Katie A Greenzang, et al.Annals of Neurology|August 19, 2023
Familial Mesial Temporal Lobe Epilepsy: Clinical Spectrum and Genetic Evidence for a Polygenic ArchitectureRebekah V Harris, Karen L Oliver, Piero Perucca, et al.Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2018
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 StudyDavid B Dix, Nita L Seibel, Yueh-Yun Chi, et al.Pediatric Blood & Cancer|May 14, 2025
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology PerspectivesKathryn S Sutton, Amy L Walz, Alissa Groenendijk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.Pageof 44